217 related articles for article (PubMed ID: 30510168)
1. Antiviral activity of bone morphogenetic proteins and activins.
Eddowes LA; Al-Hourani K; Ramamurthy N; Frankish J; Baddock HT; Sandor C; Ryan JD; Fusco DN; Arezes J; Giannoulatou E; Boninsegna S; Chevaliez S; Owens BMJ; Sun CC; Fabris P; Giordani MT; Martines D; Vukicevic S; Crowe J; Lin HY; Rehwinkel J; McHugh PJ; Binder M; Babitt JL; Chung RT; Lawless MW; Armitage AE; Webber C; Klenerman P; Drakesmith H
Nat Microbiol; 2019 Feb; 4(2):339-351. PubMed ID: 30510168
[TBL] [Abstract][Full Text] [Related]
2. Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I Receptors in Hepatocytes: Evidence for a Role in Hepcidin Induction by Inflammation in Male Mice.
Canali S; Core AB; Zumbrennen-Bullough KB; Merkulova M; Wang CY; Schneyer AL; Pietrangelo A; Babitt JL
Endocrinology; 2016 Mar; 157(3):1146-62. PubMed ID: 26735394
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation.
Takahashi M; Otsuka F; Miyoshi T; Otani H; Goto J; Yamashita M; Ogura T; Makino H; Doihara H
J Endocrinol; 2008 Dec; 199(3):445-55. PubMed ID: 18780779
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolic acid augments interferon-stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo.
Pan Q; de Ruiter PE; Metselaar HJ; Kwekkeboom J; de Jonge J; Tilanus HW; Janssen HL; van der Laan LJ
Hepatology; 2012 Jun; 55(6):1673-83. PubMed ID: 22213147
[TBL] [Abstract][Full Text] [Related]
5. Evidence for an inhibitory role of bone morphogenetic protein(s) in the follicular-luteal transition in cattle.
Kayani AR; Glister C; Knight PG
Reproduction; 2009 Jan; 137(1):67-78. PubMed ID: 18936084
[TBL] [Abstract][Full Text] [Related]
6. Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection.
Erickson AK; Seiwert S; Gale M
Antivir Ther; 2008; 13(7):851-62. PubMed ID: 19043919
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-130a is up-regulated in mouse liver by iron deficiency and targets the bone morphogenetic protein (BMP) receptor ALK2 to attenuate BMP signaling and hepcidin transcription.
Zumbrennen-Bullough KB; Wu Q; Core AB; Canali S; Chen W; Theurl I; Meynard D; Babitt JL
J Biol Chem; 2014 Aug; 289(34):23796-808. PubMed ID: 25002578
[TBL] [Abstract][Full Text] [Related]
8. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of a triterpenoid compound, with or without alpha interferon, on hepatitis C virus infection.
Watanabe T; Sakamoto N; Nakagawa M; Kakinuma S; Itsui Y; Nishimura-Sakurai Y; Ueyama M; Funaoka Y; Kitazume A; Nitta S; Kiyohashi K; Murakawa M; Azuma S; Tsuchiya K; Oooka S; Watanabe M
Antimicrob Agents Chemother; 2011 Jun; 55(6):2537-45. PubMed ID: 21444704
[TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide and Tumor Necrosis Factor Alpha Inhibit Interferon Signaling in Hepatocytes by Increasing Ubiquitin-Like Protease 18 (USP18) Expression.
MacParland SA; Ma XZ; Chen L; Khattar R; Cherepanov V; Selzner M; Feld JJ; Selzner N; McGilvray ID
J Virol; 2016 Jun; 90(12):5549-5560. PubMed ID: 27009955
[TBL] [Abstract][Full Text] [Related]
11. Erythroferrone inhibits the induction of hepcidin by BMP6.
Arezes J; Foy N; McHugh K; Sawant A; Quinkert D; Terraube V; Brinth A; Tam M; LaVallie ER; Taylor S; Armitage AE; Pasricha SR; Cunningham O; Lambert M; Draper SJ; Jasuja R; Drakesmith H
Blood; 2018 Oct; 132(14):1473-1477. PubMed ID: 30097509
[TBL] [Abstract][Full Text] [Related]
12. Interferon-inducible MX2 is a host restriction factor of hepatitis B virus replication.
Wang YX; Niklasch M; Liu T; Wang Y; Shi B; Yuan W; Baumert TF; Yuan Z; Tong S; Nassal M; Wen YM
J Hepatol; 2020 May; 72(5):865-876. PubMed ID: 31863794
[TBL] [Abstract][Full Text] [Related]
13. Iron regulation of hepcidin despite attenuated Smad1,5,8 signaling in mice without transferrin receptor 2 or Hfe.
Corradini E; Rozier M; Meynard D; Odhiambo A; Lin HY; Feng Q; Migas MC; Britton RS; Babitt JL; Fleming RE
Gastroenterology; 2011 Nov; 141(5):1907-14. PubMed ID: 21745449
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of STAT Pathway Impairs Anti-Hepatitis C Virus Effect of Interferon Alpha.
Zhao LJ; He SF; Liu Y; Zhao P; Bian ZQ; Qi ZT
Cell Physiol Biochem; 2016; 40(1-2):77-90. PubMed ID: 27855377
[TBL] [Abstract][Full Text] [Related]
16. Cyclophilin inhibitors reduce phosphorylation of RNA-dependent protein kinase to restore expression of IFN-stimulated genes in HCV-infected cells.
Daito T; Watashi K; Sluder A; Ohashi H; Nakajima S; Borroto-Esoda K; Fujita T; Wakita T
Gastroenterology; 2014 Aug; 147(2):463-72. PubMed ID: 24786893
[TBL] [Abstract][Full Text] [Related]
17. BMP6 Downregulates GDNF Expression Through SMAD1/5 and ERK1/2 Signaling Pathways in Human Granulosa-Lutein Cells.
Zhang XY; Chang HM; Taylor EL; Liu RZ; Leung PCK
Endocrinology; 2018 Aug; 159(8):2926-2938. PubMed ID: 29750278
[TBL] [Abstract][Full Text] [Related]
18. Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection.
Randall G; Chen L; Panis M; Fischer AK; Lindenbach BD; Sun J; Heathcote J; Rice CM; Edwards AM; McGilvray ID
Gastroenterology; 2006 Nov; 131(5):1584-91. PubMed ID: 17101330
[TBL] [Abstract][Full Text] [Related]
19. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
Marcello T; Grakoui A; Barba-Spaeth G; Machlin ES; Kotenko SV; MacDonald MR; Rice CM
Gastroenterology; 2006 Dec; 131(6):1887-98. PubMed ID: 17087946
[TBL] [Abstract][Full Text] [Related]
20. Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication.
Zhu H; Butera M; Nelson DR; Liu C
Virol J; 2005 Sep; 2():80. PubMed ID: 16146571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
